Previous Pause Next
Home >> News Center >>
Molecular Path from Internal Clock to Cells Controlling Rest and Activity Revealed in Penn Study PDF Print E-mail
User Rating :  / 0
Tuesday, 07 February 2012 21:23

faculty photo

PHILADELPHIA – The molecular pathway that carries time-of-day signals from the body's internal clock to ultimately guide daily behavior is like a black box, says Amita Sehgal, PhD, the John Herr Musser Professor of Neuroscience and Co-Director, Comprehensive Neuroscience Center, at the Perelman School of Medicine, University of Pennsylvania.

Now, new research from the Sehgal lab is taking a peek inside, describing a molecular pathway and its inner parts that connect the well-known clock neurons to cells governing rhythms of rest and activity in fruit flies. Sehgal is also an investigator with the Howard Hughes Medical Institute.

The other co-author on the study is Wenyu Luo, PhD, a Penn doctoral student who recently defended her dissertation. The findings, which will be featured on the cover of the February 17th issue of Cell, are published online this week.

"Most colleagues would say that we have some understanding of how the clock works and how it is synchronized with light,” says Sehgal. “But we are just beginning to get a glimpse of how the clock drives behavior in the rest of an organism's systems."

Prying the Black Box Open

Normally, flies have a robust rhythm of being active during daylight hours and quiet during the night. Sehgal and Luo essentially found that a microRNA (miRNA) named miR-279 acts through the JAK/STAT pathway to regulate locomotor activity rhythms through a daily cycling of proteins.

An miRNA is a tiny piece of RNA - a little over 20 bases (DNA building blocks) in length -- that binds to matching pieces of messenger RNA, thereby tying it up and decreasing the production of the corresponding protein.

They found that in mutant flies in which miR-279 was either overexpressed or deleted -- causing high levels or low levels of JAK/STAT signaling -- the flies wake and sleep at random intervals. The flies showed no discernible pattern of activity. Therefore, the investigators concluded that a mid-range level of JAK/STAT activity is necessary to maintain the flies' normal pattern.  In fact, they found that STAT activity displays a daily rhythm.

Part of the Clock Circuitry

Oscillations of the clock protein PERIOD are normal in clock pacemaker neurons lacking miR-279, suggesting that miR-279 acts downstream of the clock neurons. The team identified the JAK/STAT partner, a protein called Upd, as a target of miR-279. They also showed that knocking down Upd rescues the off-rhythm behavior of the miR-279 mutant flies.

In addition, in brains of mutant flies stained to identify circadian proteins, they found that the central clock neurons project their axons into the vicinity of Upd-expressing neurons, providing a possible physical connection by which the central clock could regulate JAK/STAT signaling to control rest and activity rhythms.

With these findings, the team proposed a model in which the central clock affects the cycle of secretion of the Upd protein from cells. "Upd may act like a time-release capsule," explains Sehgal. "To maintain a typical rest:activity rhythm, the level of Upd has to be just right."  

The mRNA levels of Upd in neurons are kept low by miR-279. Upd may rhythmically activate a receptor, Dome, in a third cell, which would lead to daily oscillations of JAK/STAT activity and ultimately to the rest:activity rhythm.

The direct clinical implications of knowing the players in this complicated pathway are not yet clear. But we might be able to conclude, suggests Sehgal, that, if these mechanisms are conserved in humans, then disorders in which the JAK-STAT pathway isn't working properly, as in some immune disorders, physicians might also see problems with patients' sleep-wake cycle.
These findings also provide researchers with a handle on the neural circuit that generates rest:activity behavior in Drosophila. The ultimate goal of many neurobiologists is to trace the entire molecular and cellular pathway that produces a specific behavior. This study is a step towards that goal.

The work was supported by NIH grants 1-R560NS-048471 and 2R01NS04847.

Source: University of Pennsylvania School of Medicine

 
FairExcellent 

Add comment  |   Add to my library  |  Forward this article

login to leave comment

Collaboration, Projects, & Consortia

Indiana Clinical and Translational Science Institute HUB: A model for collaboration

TGen, Karmanos Lead $6M Melanoma Project

Sanford-Burnham Medical Research Institute and Pfizer Collaborate to Speed Drug Discovery

e2v aerospace and defense and Maxim Announce an Agreement to Extend the Product Life of Maxim Ceramic ICs

Syntaxin and Ipsen Ally to Develop Botulinum Toxin Therapeutics

BioAmber and LANXESS Partner for Renewable, Phthalate-free Plasticizers

Corgenix Partners with AXA Diagnostics on SkyLAB 752™ Automated Testing Platform

GeoVax and Vivalis Sign Deal for the Biomanufacture of MVA HIV Vaccine in EB66 Cells

EMD Serono and Fast Forward Commit $3 Million for Multiple Sclerosis

VisionGate Begins Collaborations to Evaluate 3-D Cell Analysis Test for Lung Cancer Screening

>> More in: Collaboration, Projects and Consortia

Featured Experts

Featured Laboratories

Grant & Funding Opportunities

NHGRI Unveils New-Look Genome Sequencing Program; Plans $416M in Funding

NYU to Study Genetics of Obesity-Related Cancers

Researchers Get NHGRI Funding to Study Effects of Alzheimer's Risk Testing

Venture Firms Pump $18M into Fledgling Arteaus Therapeutics

Servier and miRagen Sign $352M Deal for Cardiovascular miRNA Therapeutics

Tetraphase Awarded Initial $6M by NIAID to Develop Antibiotic Against Biothreats

Dermira Announces a $42m Series A Financing to Fund Therapeutic Advances in Dermatology

Salk Institute for Biological Studies to Accelerate Brain Research With $4.5 Million National Institutes of Health (NIH) Grant

Arsanis Wins €1.2M for Research on Antibody Against Hospital-Acquired Infections

SAMHSA Awards Approximately $1.3 Million To Help Communities Offer Expanded HIV Testing, Counseling And Referral For Care

>> More in: Grant & Funding Opportunities

Appointments

Sanofi (France) Taps David Meeker as New CEO of Genzyme Corporation

Drug Information Association Appoints Kaushik Desai as DIA India Director

Sentrx Announces Resignation of Charles T. Saldarini As CEO

EKR Therapeutics Announces Senior Management Change

Amgen Appoints Robert A. Bradway to the Company's Board of Directors

Anavex Life Sciences Corp. Appoints Dr. George Tidmarsh as Executive Director

Isis Biopolymer Appoints New President and CEO

RedHill Biopharma Appoints Key Opinion Leader Professor David Y. Graham from Baylor College of Medicine, Houston, Texas, as Lead Investigator for the US Pivotal Clinical Trial with RedHill's Crohn’s Drug – RHB-104

Apceth is Extending its Top Management: Prof. Ralf Huss Moves from Roche (RHHBY) to the Biotechnology Company apceth

BioIndustry Association Board Appointments

>> More in: Appointments

Recognitions

Journal names discovery that HIV treatment can prevent spread 'breakthrough of the year'

Abbott Laboratories's Absorb(TM) Bioresorbable Vascular Scaffold Honored with Wall Street Journal Technology Innovation Award

Chris Henney Receives 2011 Hall of Fame Award at Annual Biotech CEO Meeting at Laguna Beach

Scripps Florida Scientist Awarded $2.2 Million Grant To Study Hepatitis C

SAMHSA Awards Up To $25 Million To Expand Use Of Health Information Technology

Ablitech, Inc. Awarded $2 Million

The Michael J. Fox Foundation Awards AFFiRiS AG $1.5 Million for the Clinical Development of the First Parkinson's Disease Vaccine

SAMHSA Awards Grant To UCLA For Substance Abuse Prevention In Iraq

KGI Professor Awarded Patent For Stem-Cell Therapy Aiding Heart-attack Patients

Nobel Prize for chemistry 2011 goes to Israeli scientist Daniel Shechtman

>> More in: Recognitions